These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8549238)

  • 1. Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Report of five cases and review of the literature.
    Brink HM; Beex LV
    Doc Ophthalmol; 1995; 90(1):1-6. PubMed ID: 8549238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of punctal and canalicular stenosis in patients on systemic 5-FU.
    Fezza JP; Wesley RE; Klippenstein KA
    Ophthalmic Surg Lasers; 1999 Feb; 30(2):105-8. PubMed ID: 10037204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canalicular and nasolacrimal duct blockage: an ocular side effect associated with the antineoplastic drug S-1.
    Esmaeli B; Golio D; Lubecki L; Ajani J
    Am J Ophthalmol; 2005 Aug; 140(2):325-7. PubMed ID: 16086962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Punctal-canalicular stenosis related to systemic fluorouracil therapy.
    Caravella LP; Burns JA; Zangmeister M
    Arch Ophthalmol; 1981 Feb; 99(2):284-6. PubMed ID: 7469866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerosing canaliculitis after 5-fluorouracil breast cancer chemotherapy.
    Lee V; Bentley CR; Olver JM
    Eye (Lond); 1998; 12 ( Pt 3a)():343-9. PubMed ID: 9775228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacrimal canalicular stenosis associated with systemic 5-fluorouacil therapy.
    Prasad S; Kamath GG; Phillips RP
    Acta Ophthalmol Scand; 2000 Feb; 78(1):110-3. PubMed ID: 10726804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous metaplasia of the canaliculi associated with 5-fluorouracil: a clinicopathologic case report.
    Agarwal MR; Esmaeli B; Burnstine MA
    Ophthalmology; 2002 Dec; 109(12):2359-61. PubMed ID: 12466185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy.
    Esmaeli B; Hidaji L; Adinin RB; Faustina M; Coats C; Arbuckle R; Rivera E; Valero V; Tu SM; Ahmadi MA
    Cancer; 2003 Aug; 98(3):504-7. PubMed ID: 12879466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer.
    Esmaeli B; Hortobagyi GN; Esteva FJ; Booser D; Ahmadi MA; Rivera E; Arbuckle R; Delpassand E; Guerra L; Valero V
    Ophthalmology; 2002 Jun; 109(6):1188-91. PubMed ID: 12045065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical treatment of punctal-canalicular fibrosis from 5-fluorouracil therapy.
    Seiff SR; Shorr N; Adams T
    Cancer; 1985 Oct; 56(8):2148-9. PubMed ID: 4027942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of canalicular stenosis in patients receiving docetaxel weekly.
    Ahmadi MA; Esmaeli B
    Arch Ophthalmol; 2001 Dec; 119(12):1802-4. PubMed ID: 11735790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dacryoendoscopic observation and incidence of canalicular obstruction/stenosis associated with S-1, an oral anticancer drug.
    Sasaki T; Miyashita H; Miyanaga T; Yamamoto K; Sugiyama K
    Jpn J Ophthalmol; 2012 May; 56(3):214-8. PubMed ID: 22411166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epiphora in patients receiving systemic 5-fluorouracil therapy.
    Hassan A; Hurwitz JJ; Burkes RL
    Can J Ophthalmol; 1998 Feb; 33(1):14-9. PubMed ID: 9513767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation and Management of Chemotherapy-Induced Epiphora, Punctal and Canalicular Stenosis, and Nasolacrimal Duct Obstruction.
    Mansur C; Pfeiffer ML; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2017; 33(1):9-12. PubMed ID: 27429222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.
    Esmaeli B; Valero V; Ahmadi MA; Booser D
    Ophthalmology; 2001 May; 108(5):994-5. PubMed ID: 11320034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Punctal-canalicular stenosis associated with mitomycin-C for corneal epithelial dysplasia.
    Billing K; Karagiannis A; Selva D
    Am J Ophthalmol; 2003 Oct; 136(4):746-7. PubMed ID: 14516822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lacrimal duct stenosis and other ocular toxicity associated with adjuvant cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy for early stage breast cancer.
    Stevens A; Spooner D
    Clin Oncol (R Coll Radiol); 2001; 13(6):438-40. PubMed ID: 11824881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upper and lower system nasolacrimal duct stenosis secondary to paclitaxel.
    McCartney E; Valluri S; Rushing D; Burgett R
    Ophthalmic Plast Reconstr Surg; 2007; 23(2):170-1. PubMed ID: 17413646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacrimal canalicular obstruction associated with topical ocular medication.
    McNab AA
    Aust N Z J Ophthalmol; 1998 Aug; 26(3):219-23. PubMed ID: 9717753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
    Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
    JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.